BRISTOL-MYERS SQUIBB CO revenue for the last year amounted to 48.30 B USD, the most of which — 48.30 B USD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 45.01 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought BRISTOL-MYERS SQUIBB CO 34.10 B USD, and the year before that — 31.55 B USD.